Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Finerenone is the first mineralocorticoid receptor (MR) antagonist to demonstrate definitive cardiovascular benefits in a Phase III study in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ?40%
The partnership marks a significant milestone in integrating digital health education into medical curricula
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for treatment of dry eye syndrome
The pooled prevalence of GERD in the Indian population is 15.6 %
Subscribe To Our Newsletter & Stay Updated
